Bojana Lucic

Dr. Bojana Lucic

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2013 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
MBMatteo Berti
Matteo Berti
ACArnab Ray Chaudhuri
Arnab Ray Chaudhuri
STSaravanabhavan Thangavel
Saravanabhavan Thangavel
SGShivasankari Gomathinayagam
Shivasankari Gomathinayagam
SKSaša Kenig
Saša Kenig
AVAlessandro Vindigni
Alessandro Vindigni
The cytotoxic effects of topoisomerase I inhibitors such as camptothecin can be modulated by replication fork reversal, in a process that requires Poly(ADP-ribose) polymerase (PARP) activity. Here human RECQ1 helicase is shown to restore such regressed replication forks, whereas PARP1 activity restrains this RECQ1 function. Topoisomerase I (TOP1) inhibitors are an important class of anticancer drugs. The cytotoxicity of TOP1 inhibitors can be modulated by replication fork reversal through a process that requires poly(ADP-ribose) polymerase (PARP) activity. Whether regressed forks can efficiently restart and what factors are required to restart fork progression after fork reversal are still unknown. We have combined biochemical and EM approaches with single-molecule DNA fiber analysis to identify a key role for human RECQ1 helicase in replication fork restart after TOP1 inhibition that is not shared by other human RecQ proteins. We show that the poly(ADP-ribosyl)ation activity of PARP1 stabilizes forks in the regressed state by limiting their restart by RECQ1. These studies provide new mechanistic insights into the roles of RECQ1 and PARP in DNA replication and offer molecular perspectives to potentiate chemotherapeutic regimens based on TOP1 inhibition.

2 March 2015 in Nature
Verified
Journal Article
Closed access
BMBruna Marini
Bruna Marini
AKAttila Kertesz-Farkas
Attila Kertesz-Farkas
Hashim AliHashim Ali
Hashim Ali
BLBojana Lucic
Bojana Lucic
KLKamil Lisek
Kamil Lisek
MLMarina Lusic
Marina Lusic

23 January 2019 in eLife
Verified
Journal Article
Open access
DBDavid Alejandro Bejarano
David Alejandro Bejarano
Ke PengKe Peng
Ke Peng
VLVibor Laketa
Vibor Laketa
KBKathleen Börner
Kathleen Börner
KJK Laurence Jost
K Laurence Jost
HKHans-Georg Krausslich
Hans-Georg Krausslich
Nuclear entry of HIV-1 replication complexes through intact nuclear pore complexes is critical for successful infection. The host protein cleavage-and-polyadenylation-specificity-factor-6 (CPSF6) has been implicated in different stages of early HIV-1 replication. Applying quantitative microscopy of HIV-1 reverse-transcription and pre-integration-complexes (RTC/PIC), we show that CPSF6 is strongly recruited to nuclear replication complexes but absent from cytoplasmic RTC/PIC in primary human macrophages. Depletion of CPSF6 or lack of CPSF6 binding led to accumulation of HIV-1 subviral complexes at the nuclear envelope of macrophages and reduced infectivity. Two-color stimulated-emission-depletion microscopy indicated that under these circumstances HIV-1 complexes are retained inside the nuclear pore and undergo CA-multimer dependent CPSF6 clustering adjacent to the nuclear basket. We propose that nuclear entry of HIV-1 subviral complexes in macrophages is mediated by consecutive binding of Nup153 and CPSF6 to the hexameric CA lattice.

27 April 2021 in eLife
Verified
Journal Article
Open access
TMThorsten Müller
Thorsten Müller
VZVojtech Zila
Vojtech Zila
KPKyra Peters
Kyra Peters
SSSandra Schifferdecker
Sandra Schifferdecker
MSMia Stanic
Mia Stanic
HKHans-Georg Krausslich
Hans-Georg Krausslich
HIV-1 replication commences inside the cone-shaped viral capsid, but timing, localization, and mechanism of uncoating are under debate. We adapted a strategy to visualize individual reverse-transcribed HIV-1 cDNA molecules and their association with viral and cellular proteins using fluorescence and correlative-light-and-electron-microscopy (CLEM). We specifically detected HIV-1 cDNA inside nuclei, but not in the cytoplasm. Nuclear cDNA initially co-localized with a fluorescent integrase fusion (IN-FP) and the viral CA (capsid) protein, but cDNA-punctae separated from IN-FP/CA over time. This phenotype was conserved in primary HIV-1 target cells, with nuclear HIV-1 complexes exhibiting strong CA-signals in all cell types. CLEM revealed cone-shaped HIV-1 capsid-like structures and apparently broken capsid-remnants at the position of IN-FP signals and elongated chromatin-like structures in the position of viral cDNA punctae lacking IN-FP. Our data argue for nuclear uncoating by physical disruption rather than cooperative disassembly of the CA-lattice, followed by physical separation from the pre-integration complex.

1 June 2013 in Cell Host & Microbe
Verified
Journal Article
Closed access
MLMarina Lusic
Marina Lusic
BMBruna Marini
Bruna Marini
Hashim AliHashim Ali
Hashim Ali
BLBojana Lucic
Bojana Lucic
RLROBERTO Luzzati
ROBERTO Luzzati
MGMauro Giacca
Mauro Giacca

6 September 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
BLBojana Lucic
Bojana Lucic
HCHeng-Chang Chen
Heng-Chang Chen
MKMaja Kuzman
Maja Kuzman
EZEduard Zorita
Eduard Zorita
JWJulia Wegner
Julia Wegner
MLMarina Lusic
Marina Lusic
HIV-1 recurrently targets active genes and integrates in the proximity of the nuclear pore compartment in CD4+ T cells. However, the genomic features of these genes and the relevance of their transcriptional activity for HIV-1 integration have so far remained unclear. Here we show that recurrently targeted genes are proximal to super-enhancer genomic elements and that they cluster in specific spatial compartments of the T cell nucleus. We further show that these gene clusters acquire their location during the activation of T cells. The clustering of these genes along with their transcriptional activity are the major determinants of HIV-1 integration in T cells. Our results provide evidence of the relevance of the spatial compartmentalization of the genome for HIV-1 integration, thus further strengthening the role of nuclear architecture in viral infection.